A 68-year-old woman with chronic atrial fibrillation and a history of rheumatic mitral stenosis presents with acute dyspnea and orthopnea. On examination, she is tachypneic (RR 28/min), has a loud opening snap followed by a long diastolic murmur, and bilateral crackles on auscultation. Chest X-ray shows pulmonary edema. Echocardiography confirms severe mitral stenosis (mitral valve area 0.8 cm²) with rapid ventricular response (HR 140/min). What is the most appropriate immediate next step in management?

Explanation

## Clinical Scenario: Acute Decompensated Mitral Stenosis with Rapid AF This patient has severe mitral stenosis (MS) with uncontrolled atrial fibrillation (AF) causing acute pulmonary edema. The rapid ventricular response (140/min) is the primary driver of hemodynamic decompensation because it shortens diastolic filling time, the critical phase for blood flow across the stenotic mitral valve. ## Pathophysiology of Mitral Stenosis During Diastole **Key Point:** The mitral valve opens during early diastole (after aortic valve closure). In MS: - The narrowed orifice (0.8 cm² is severe; normal ≈ 4–6 cm²) restricts flow from LA to LV - Diastolic filling time is the only period when LA-to-LV flow occurs - Rapid ventricular response (short diastolic intervals) → inadequate LA emptying → LA pressure rises → pulmonary edema **Mnemonic: DIASTOLE IS EVERYTHING IN MS** — Diastolic time is the only opportunity for filling; shorten it and the patient decompensates. ## Why Rate Control First? 1. **Restore diastolic filling time:** - Slowing HR from 140 to 80–100 bpm lengthens diastole - Allows more time for blood to cross the stenotic mitral valve - Reduces LA pressure and pulmonary congestion 2. **Digoxin is the agent of choice in MS + AF:** - Negative chronotropic effect (slows AV nodal conduction) - Positive inotropic effect (improves LV contractility despite reduced filling) - Vagomimetic action (enhances AV block) - Intravenous route provides rapid onset 3. **Diuretics (furosemide):** - Reduce pulmonary edema acutely - Lower LA pressure by reducing circulating volume - Essential for symptomatic relief **High-Yield:** In acute MS with rapid AF: **Rate control + diuretics = immediate stabilization.** Structural intervention (commissurotomy or valve replacement) is elective, not emergent, once the patient is hemodynamically stable. **Clinical Pearl:** Beta-blockers and calcium channel blockers are relatively contraindicated in MS because their negative inotropic effects reduce LV contractility, which is already compromised by inadequate filling. Digoxin's inotropic benefit makes it superior in this setting. ## Cardiac Cycle Correlation The diastolic phase is when the mitral valve is open and the LV fills from the LA. In MS, this phase is the bottleneck. Rapid HR (short diastole) → inadequate filling → elevated LA pressure → pulmonary edema. Slowing HR restores diastolic time and allows adequate filling despite the stenotic valve.